1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide

C155H134N32O14 — CID 162012665

IUPAC1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide
SMILESCc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)N1CCC2(CC1)CC(=O)Nc1ncccc12.Cc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)Nc1ccc2c(c1)CCC1(C2)NC(=O)NC1=O.Cc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)c1ccc2c(c1)CC1(C2)NC(=O)NC1=O.Cc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)c1ccc2c(c1)CCC1(C2)C(=O)NC(=O)N1C.Cc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)c1ccc2c(c1)CCC1(C2)NC(=O)NC1=O
InChIInChI=1S/C32H28N6O3.C31H27N7O3.C31H29N7O2.C31H26N6O3.C30H24N6O3/c1-19-18-33-28-27(34-26(20-8-4-3-5-9-20)24-10-6-7-11-25(24)38(19)28)35-29(39)22-12-13-23-17-32(15-14-21(23)16-22)30(40)36-31(41)37(32)2;1-18-17-32-27-26(34-25(19-7-3-2-4-8-19)23-9-5-6-10-24(23)38(18)27)35-29(40)33-22-12-11-21-16-31(14-13-20(21)15-22)28(39)36-30(41)37-31;1-20-19-33-29-28(35-26(21-8-3-2-4-9-21)22-10-5-6-12-24(22)38(20)29)36-30(40)37-16-13-31(14-17-37)18-25(39)34-27-23(31)11-7-15-32-27;1-18-17-32-27-26(33-25(19-7-3-2-4-8-19)23-9-5-6-10-24(23)37(18)27)34-28(38)21-11-12-22-16-31(14-13-20(22)15-21)29(39)35-30(40)36-31;1-17-16-31-26-25(32-24(18-7-3-2-4-8-18)22-9-5-6-10-23(22)36(17)26)33-27(37)19-11-12-20-14-30(15-21(20)13-19)28(38)34-29(39)35-30/h3-13,16,18,27H,14-15,17H2,1-2H3,(H,35,39)(H,36,40,41);2-12,15,17,26H,13-14,16H2,1H3,(H2,33,35,40)(H2,36,37,39,41);2-12,15,19,28H,13-14,16-18H2,1H3,(H,36,40)(H,32,34,39);2-12,15,17,26H,13-14,16H2,1H3,(H,34,38)(H2,35,36,39,40);2-13,16,25H,14-15H2,1H3,(H,33,37)(H2,34,35,38,39)
InChIKeyYTRIXBLBNUTGLI-UHFFFAOYSA-N
MW2668.99 g/mol
LogP18.96
Rot. Bonds14

About 1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide

1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide (PubChem CID 162012665) has the molecular formula C155H134N32O14 and a molecular weight of 2668.99 g/mol. Its IUPAC name is 1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide.

Molecular Properties

Compound Name1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide
PubChem CID162012665
Molecular FormulaC155H134N32O14
Molecular Weight2668.99 g/mol
Exact Mass2667.08
IUPAC Name1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide
SMILESCc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)N1CCC2(CC1)CC(=O)Nc1ncccc12.Cc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)Nc1ccc2c(c1)CCC1(C2)NC(=O)NC1=O.Cc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)c1ccc2c(c1)CC1(C2)NC(=O)NC1=O.Cc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)c1ccc2c(c1)CCC1(C2)C(=O)NC(=O)N1C.Cc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)c1ccc2c(c1)CCC1(C2)NC(=O)NC1=O
InChIInChI=1S/C32H28N6O3.C31H27N7O3.C31H29N7O2.C31H26N6O3.C30H24N6O3/c1-19-18-33-28-27(34-26(20-8-4-3-5-9-20)24-10-6-7-11-25(24)38(19)28)35-29(39)22-12-13-23-17-32(15-14-21(23)16-22)30(40)36-31(41)37(32)2;1-18-17-32-27-26(34-25(19-7-3-2-4-8-19)23-9-5-6-10-24(23)38(18)27)35-29(40)33-22-12-11-21-16-31(14-13-20(21)15-22)28(39)36-30(41)37-31;1-20-19-33-29-28(35-26(21-8-3-2-4-9-21)22-10-5-6-12-24(22)38(20)29)36-30(40)37-16-13-31(14-17-37)18-25(39)34-27-23(31)11-7-15-32-27;1-18-17-32-27-26(33-25(19-7-3-2-4-8-19)23-9-5-6-10-24(23)37(18)27)34-28(38)21-11-12-22-16-31(14-13-20(22)15-21)29(39)35-30(40)36-31;1-17-16-31-26-25(32-24(18-7-3-2-4-8-18)22-9-5-6-10-23(22)36(17)26)33-27(37)19-11-12-20-14-30(15-21(20)13-19)28(38)34-29(39)35-30/h3-13,16,18,27H,14-15,17H2,1-2H3,(H,35,39)(H,36,40,41);2-12,15,17,26H,13-14,16H2,1H3,(H2,33,35,40)(H2,36,37,39,41);2-12,15,19,28H,13-14,16-18H2,1H3,(H,36,40)(H,32,34,39);2-12,15,17,26H,13-14,16H2,1H3,(H,34,38)(H2,35,36,39,40);2-13,16,25H,14-15H2,1H3,(H,33,37)(H2,34,35,38,39)
InChIKeyYTRIXBLBNUTGLI-UHFFFAOYSA-N
XLogP18.96
TPSA577.67 Ų
H-Bond Donors14
H-Bond Acceptors30
Rotatable Bonds14
Heavy Atoms201
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002668.99
LogP ≤ 518.96
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze 1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide?
The IUPAC name of 1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide (CID 162012665) is 1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide.
What is the SMILES notation for 1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide?
The canonical SMILES for 1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide is Cc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)N1CCC2(CC1)CC(=O)Nc1ncccc12.Cc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)Nc1ccc2c(c1)CCC1(C2)NC(=O)NC1=O.Cc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)c1ccc2c(c1)CC1(C2)NC(=O)NC1=O.Cc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)c1ccc2c(c1)CCC1(C2)C(=O)NC(=O)N1C.Cc1cnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)c1ccc2c(c1)CCC1(C2)NC(=O)NC1=O.
What is the InChIKey of 1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide?
The InChIKey is YTRIXBLBNUTGLI-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H28N6O3.C31H27N7O3.C31H29N7O2.C31H26N6O3.C30H24N6O3/c1-19-18-33-28-27(34-26(20-8-4-3-5-9-20)24-10-6-7-11-25(24)38(19)28)35-29(39)22-12-13-23-17-32(15-14-21(23)16-22)30(40)36-31(41)37(32)2;1-18-17-32-27-26(34-25(19-7-3-2-4-8-19)23-9-5-6-10-24(23)38(18)27)35-29(40)33-22-12-11-21-16-31(14-13-20(21)15-22)28(39)36-30(41)37-31;1-20-19-33-29-28(35-26(21-8-3-2-4-9-21)22-10-5-6-12-24(22)38(20)29)36-30(40)37-16-13-31(14-17-37)18-25(39)34-27-23(31)11-7-15-32-27;1-18-17-32-27-26(33-25(19-7-3-2-4-8-19)23-9-5-6-10-24(23)37(18)27)34-28(38)21-11-12-22-16-31(14-13-20(22)15-21)29(39)35-30(40)36-31;1-17-16-31-26-25(32-24(18-7-3-2-4-8-18)22-9-5-6-10-23(22)36(17)26)33-27(37)19-11-12-20-14-30(15-21(20)13-19)28(38)34-29(39)35-30/h3-13,16,18,27H,14-15,17H2,1-2H3,(H,35,39)(H,36,40,41);2-12,15,17,26H,13-14,16H2,1H3,(H2,33,35,40)(H2,36,37,39,41);2-12,15,19,28H,13-14,16-18H2,1H3,(H,36,40)(H,32,34,39);2-12,15,17,26H,13-14,16H2,1H3,(H,34,38)(H2,35,36,39,40);2-13,16,25H,14-15H2,1H3,(H,33,37)(H2,34,35,38,39).
What are the key properties of 1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide?
1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide has a molecular weight of 2668.99 g/mol, XLogP of 18.96, 14 rotatable bonds, 14 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-yl)-3-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)urea;1'-methyl-N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',4'-dioxospiro[7,8-dihydro-5H-naphthalene-6,5'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[1,3-dihydroindene-2,4'-imidazolidine]-5-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2',5'-dioxospiro[7,8-dihydro-5H-naphthalene-6,4'-imidazolidine]-2-carboxamide;N-(1-methyl-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl)-2-oxospiro[1,3-dihydro-1,8-naphthyridine-4,4'-piperidine]-1'-carboxamide is sourced from PubChem (CID 162012665), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).